{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:25:04Z","timestamp":1793975104318,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:00:00Z","timestamp":1791072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0548200"],"award-info":[{"award-number":["2025ZD0548200"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.metop.2026.100505","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:57:58Z","timestamp":1791183478000},"page":"100505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiometabolic medicine in China: Burden, challenges, and strategic priorities"],"prefix":"10.1016","volume":"32","author":[{"given":"Rui-Xiang","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Fei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"32","key":"10.1016\/j.metop.2026.100505_bib1","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehaf368","article-title":"CardioMetabolic medicine: the advent of systems cardiology and the new cardiovascular generalist?","volume":"46","author":"L\u00fcscher","year":"2025","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.metop.2026.100505_bib2","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/eurheartj\/ehab713","article-title":"CardioMetabolic medicine, one more last step forward","volume":"43","author":"Carbone","year":"2022","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.metop.2026.100505_bib3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.amjmed.2019.02.027","article-title":"Cardiometabolic medicine: a call for a new subspeciality training track in internal medicine","volume":"132","author":"Eckel","year":"2019","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.metop.2026.100505_bib4","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1210\/clinem\/dgaa261","article-title":"Cardiometabolic medicine: development of a new subspecialty","volume":"105","author":"Saxon","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.metop.2026.100505_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/XCE.0000000000000173","article-title":"Cardiometabolic medicine: time to recognize a new clinical specialty?","volume":"8","author":"Krentz","year":"2019","journal-title":"Cardiovasc Endocrinol Metab"},{"issue":"27","key":"10.1016\/j.metop.2026.100505_bib6","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1093\/eurheartj\/ehaf1121","article-title":"Cardiovascular disease in China: epidemiological evolution and implications","volume":"47","author":"Qi","year":"2026","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.metop.2026.100505_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12933-022-01551-3","article-title":"Landscape of cardiometabolic risk factors in Chinese population: a narrative review","volume":"21","author":"Li","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.metop.2026.100505_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-55-1-33","article-title":"Factors of risk in the development of coronary heart disease--six year follow-up experience. The framingham study","volume":"55","author":"Kannel","year":"1961","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.metop.2026.100505_bib9","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.metop.2026.100505_bib10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"issue":"19","key":"10.1016\/j.metop.2026.100505_bib11","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"9491","key":"10.1016\/j.metop.2026.100505_bib12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.metop.2026.100505_bib13","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.2337\/diacare.28.9.2289","article-title":"The metabolic syndrome: time for a critical appraisal: joint statement from the American diabetes association and the european association for the study of diabetes","volume":"28","author":"Kahn","year":"2005","journal-title":"Diabetes Care"},{"issue":"7121","key":"10.1016\/j.metop.2026.100505_bib14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"issue":"20","key":"10.1016\/j.metop.2026.100505_bib15","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"22S","key":"10.1016\/j.metop.2026.100505_bib16","doi-asserted-by":"crossref","first-page":"e1889","DOI":"10.1016\/j.jacc.2026.03.056","article-title":"AHA\/ACC\/ADA\/ASN guideline for the prevention, detection, evaluation, and management of cardiovascular-kidney-metabolic syndrome: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"87","author":"Ndumele","year":"2026","journal-title":"J Am Coll Cardiol"},{"issue":"9753","key":"10.1016\/j.metop.2026.100505_bib17","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.metop.2026.100505_bib18","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the european atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.metop.2026.100505_bib19","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"National burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023","volume":"86","author":"Global","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.metop.2026.100505_bib20","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","article-title":"Global burden of cardiovascular diseases and risks collaboration, 1990-2021","volume":"80","author":"Lindstrom","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"10166","key":"10.1016\/j.metop.2026.100505_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.metop.2026.100505_bib22","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.metop.2026.100505_bib23","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"24","key":"10.1016\/j.metop.2026.100505_bib24","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"38","key":"10.1016\/j.metop.2026.100505_bib25","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/eurheartj\/ehae508","article-title":"Obesity and cardiovascular disease: an ESC clinical consensus statement","volume":"45","author":"Koskinas","year":"2024","journal-title":"Eur Heart J"},{"issue":"12","key":"10.1016\/j.metop.2026.100505_bib26","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.numecd.2024.09.004","article-title":"Organisational initiatives to improve care in the prevention and management of cardiometabolic conditions: a scoping review","volume":"34","author":"Habte-Asres","year":"2024","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.metop.2026.100505_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007682","article-title":"Cardiometabolic center of excellence: a novel care delivery model for secondary prevention of cardiovascular disease in type 2 diabetes","volume":"14","author":"Thomas","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"15","key":"10.1016\/j.metop.2026.100505_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.024482","article-title":"Lessons learned from a patient-centered, team-based intervention for patients with type 2 diabetes at high cardiovascular risk: year 1 results from the CINEMA program","volume":"11","author":"Neeland","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metop.2026.100505_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2024.100706","article-title":"Role and impact of a specialized cardiometabolic clinic in managing high-risk patients with type 2 diabetes and atherosclerotic cardiovascular disease","volume":"19","author":"Modarressi","year":"2024","journal-title":"Am J Prev Cardiol"},{"issue":"7","key":"10.1016\/j.metop.2026.100505_bib30","article-title":"Optimizing care in cardiovascular-kidney-metabolic syndrome: registry data from the cardiometabolic center alliance","volume":"19","author":"Neeland","year":"2026","journal-title":"Circ Popul Health Outcomes"},{"issue":"3","key":"10.1016\/j.metop.2026.100505_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5334\/ijic.7744","article-title":"Effectiveness of integrated care for diabetes mellitus type 2, cardiovascular and chronic respiratory diseases: a systematic review and meta-analysis","volume":"24","author":"Valentijn","year":"2024","journal-title":"Int J Integrated Care"},{"issue":"1","key":"10.1016\/j.metop.2026.100505_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00125-018-4740-x","article-title":"Clinical outcomes of an integrated primary-secondary model of care for individuals with complex type 2 diabetes: a non-inferiority randomised controlled trial","volume":"62","author":"Russell","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.metop.2026.100505_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1071\/AH19226","article-title":"Community-based integrated care versus hospital outpatient care for managing patients with complex type 2 diabetes: costing analysis","volume":"45","author":"Donald","year":"2021","journal-title":"Aust Health Rev"},{"key":"10.1016\/j.metop.2026.100505_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2026.101519","article-title":"Development, structure, and implementation of cardiometabolic clinics in the United States, with a focus on comprehensive patient care","volume":"27","author":"Sweeney","year":"2026","journal-title":"Am J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.metop.2026.100505_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/dom.70222","article-title":"Control of the cardiovascular risk factors in patients with type 2 diabetes mellitus in China in 2023-2024","volume":"28","author":"Yang","year":"2026","journal-title":"Diabetes Obes Metabol"},{"issue":"12","key":"10.1016\/j.metop.2026.100505_bib36","doi-asserted-by":"crossref","first-page":"e1025","DOI":"10.1016\/S2468-2667(24)00211-1","article-title":"Trends and inequalities in thinness and obesity among Chinese children and adolescents: evidence from seven national school surveys between 1985 and 2019","volume":"9","author":"Song","year":"2024","journal-title":"Lancet Public Health"},{"issue":"24","key":"10.1016\/j.metop.2026.100505_bib37","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013-2018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"issue":"8 Pt 2","key":"10.1016\/j.metop.2026.100505_bib38","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacasi.2026.05.005","article-title":"Trends in cardiovascular diseases burden in China, 1990-2023: a global burden of disease analysis","volume":"6","author":"Shi","year":"2026","journal-title":"JACC Asia"},{"key":"10.1016\/j.metop.2026.100505_bib39","article-title":"2023 Chinese guideline for lipid management","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"issue":"10112","key":"10.1016\/j.metop.2026.100505_bib40","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/S0140-6736(17)33109-4","article-title":"The primary health-care system in China","volume":"390","author":"Li","year":"2017","journal-title":"Lancet"},{"issue":"10239","key":"10.1016\/j.metop.2026.100505_bib41","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(20)30122-7","article-title":"Quality of primary health care in China: challenges and recommendations","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.metop.2026.100505_bib42","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1097\/HJH.0000000000000994","article-title":"Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry","volume":"34","author":"Song","year":"2016","journal-title":"J Hypertens"},{"issue":"1","key":"10.1016\/j.metop.2026.100505_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1753-0407.12847","article-title":"Metabolic management center: an innovation project for the management of metabolic diseases and complications in China","volume":"11","author":"Zhang","year":"2019","journal-title":"J Diabetes"},{"issue":"9","key":"10.1016\/j.metop.2026.100505_bib44","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00592-020-01518-4","article-title":"Comparison and analyses of therapeutic effects between metabolic management center (MMC) and conventional management modes","volume":"57","author":"Wang","year":"2020","journal-title":"Acta Diabetol"},{"issue":"5","key":"10.1016\/j.metop.2026.100505_bib45","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/jdi.14414","article-title":"Biomedical outcomes and cardiovascular risks in Chinese adults with type 2 diabetes in the metabolic management center program: a longitudinal comparative study","volume":"16","author":"He","year":"2025","journal-title":"J Diabetes Investig"},{"issue":"7","key":"10.1016\/j.metop.2026.100505_bib46","first-page":"656","article-title":"[Chinese expert consensus on comprehensive management of cardiovascular risk in patients with cardiovascular diseases and abnormal glucose metabolism]","volume":"49","year":"2021","journal-title":"Zhonghua Xinxueguanbing Zazhi"},{"issue":"4","key":"10.1016\/j.metop.2026.100505_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2478\/jtim-2024-0014","article-title":"Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition)","volume":"12","author":"Xiao","year":"2024","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.metop.2026.100505_bib48","article-title":"The development and progress of health literacy in China","volume":"10","author":"Li","year":"2022","journal-title":"Front Public Health"},{"issue":"9","key":"10.1016\/j.metop.2026.100505_bib49","doi-asserted-by":"crossref","first-page":"11304","DOI":"10.3390\/ijerph120911304","article-title":"Factors influencing self-management in Chinese adults with type 2 diabetes: a systematic review and meta-analysis","volume":"12","author":"Luo","year":"2015","journal-title":"Int J Environ Res Publ Health"},{"issue":"9","key":"10.1016\/j.metop.2026.100505_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003754","article-title":"Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): a cluster randomized trial","volume":"18","author":"Jia","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.metop.2026.100505_bib51","article-title":"Improving the management of type 2 diabetes in China using a multifaceted digital health intervention in primary health care: the SMARTDiabetes cluster randomised controlled trial","volume":"49","author":"Zhang","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"issue":"11","key":"10.1016\/j.metop.2026.100505_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-109437","article-title":"Using electronic health records to improve cardiovascular-kidney-metabolic health: a protocol for the China cardiovascular-kidney-metabolic Cohort-WeinAn REsearch (CKM-CARE)","volume":"15","author":"Wu","year":"2025","journal-title":"BMJ Open"},{"issue":"25","key":"10.1016\/j.metop.2026.100505_bib53","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.jacc.2025.11.014","article-title":"Heart failure and hypertension in the metabolic era: 2 atlases, 1 message","volume":"86","author":"Krumholz","year":"2025","journal-title":"J Am Coll Cardiol"},{"issue":"10486","key":"10.1016\/j.metop.2026.100505_bib54","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(25)00055-8","article-title":"The lancet commission on rethinking coronary artery disease: moving from ischaemia to atheroma","volume":"405","author":"Zaman","year":"2025","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.metop.2026.100505_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2025-003874","article-title":"When cardiology forgets to ask why","volume":"12","author":"Tona","year":"2025","journal-title":"Open Heart"},{"issue":"9","key":"10.1016\/j.metop.2026.100505_bib56","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jacc.2015.06.1328","article-title":"The CardioMetabolic health alliance: working toward a new care model for the metabolic syndrome","volume":"66","author":"Sperling","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.metop.2026.100505_bib57","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10488-010-0319-7","article-title":"Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda","volume":"38","author":"Proctor","year":"2011","journal-title":"Adm Pol Ment Health"},{"issue":"3","key":"10.1016\/j.metop.2026.100505_bib58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jacasi.2026.01.001","article-title":"Asia at the epicenter of the global cardiometabolic shift","volume":"6","author":"Khanna","year":"2026","journal-title":"JACC Asia"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936826000642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936826000642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:29:25Z","timestamp":1793971765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936826000642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":58,"alternative-id":["S2589936826000642"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2026.100505","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiometabolic medicine in China: Burden, challenges, and strategic priorities","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2026.100505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100505"}}